WHO Grade 3 Glioma Active Not Recruiting Phase 2 Trials for Sildenafil (DB00203)

Also known as: WHO Grade III Gliomas / Grade III Glioma / WHO Grade III Glioma

IndicationStatusPhase
DBCOND0146359 (WHO Grade 3 Glioma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01817751Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade GliomaTreatment